Review on COVID-19: Rise of SARS-CoV-2 Pandemic Outbreak
Initially recognized of COVID-19 within the world in 2019, the World Health Organization situational report from May 22nd, 2020, globally, there is a complete of 5,204,508 confirmed cases, with 212 countries being affected by the novel coronavirus. 2019 novel coronavirus (SARS-CoV-2) is that the seventh member of the family of coronaviruses is enveloped viruses with a positive sense, single-stranded RNA genome. The SARS-CoV-2 may be a β-CoV of group 2B there is 70% comparability in genetic sequence to SARS-CoV. The source of the new coronavirus infection has been resolved as bats. With whole-genome sequences of SARS-CoV-2 is 96% comparatively at the whole-genome level to a bat coronavirus. Mechanisms of transmission are concluded to incorporate contact, droplet, and possibly airborne under certain circumstances supported ancient experiences associated with SARS-CoV outbreaks. Although antiretroviral therapy is being widely used everywhere the globe for such patents, effects at finding a SARS-CoV vaccine haven’t succeeded so far..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
|---|---|
| Enthalten in: |
Borneo Journal of Pharmacy - 3(2020), Special-1, Seite 103-120 |
| Sprache: |
Englisch ; Indonesisch |
|---|
| Beteiligte Personen: |
Vidhan Chand Bala [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
2019-ncov |
|---|
| doi: |
10.33084/bjop.v3iSpecial-1.1412 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ038520885 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ038520885 | ||
| 003 | DE-627 | ||
| 005 | 20230308022457.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.33084/bjop.v3iSpecial-1.1412 |2 doi | |
| 035 | |a (DE-627)DOAJ038520885 | ||
| 035 | |a (DE-599)DOAJ8bed79ee3c4d48b1a98b5f4584c642d0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a ind | ||
| 050 | 0 | |a RS1-441 | |
| 100 | 0 | |a Vidhan Chand Bala |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Review on COVID-19: Rise of SARS-CoV-2 Pandemic Outbreak |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Initially recognized of COVID-19 within the world in 2019, the World Health Organization situational report from May 22nd, 2020, globally, there is a complete of 5,204,508 confirmed cases, with 212 countries being affected by the novel coronavirus. 2019 novel coronavirus (SARS-CoV-2) is that the seventh member of the family of coronaviruses is enveloped viruses with a positive sense, single-stranded RNA genome. The SARS-CoV-2 may be a β-CoV of group 2B there is 70% comparability in genetic sequence to SARS-CoV. The source of the new coronavirus infection has been resolved as bats. With whole-genome sequences of SARS-CoV-2 is 96% comparatively at the whole-genome level to a bat coronavirus. Mechanisms of transmission are concluded to incorporate contact, droplet, and possibly airborne under certain circumstances supported ancient experiences associated with SARS-CoV outbreaks. Although antiretroviral therapy is being widely used everywhere the globe for such patents, effects at finding a SARS-CoV vaccine haven’t succeeded so far. | ||
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a 2019-ncov | |
| 650 | 4 | |a sars-cov | |
| 650 | 4 | |a mers-cov | |
| 653 | 0 | |a Pharmacy and materia medica | |
| 700 | 0 | |a Punet Kumar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Borneo Journal of Pharmacy |d Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya, 2019 |g 3(2020), Special-1, Seite 103-120 |w (DE-627)DOAJ00011300X |x 26214814 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2020 |g number:Special-1 |g pages:103-120 |
| 856 | 4 | 0 | |u https://doi.org/10.33084/bjop.v3iSpecial-1.1412 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/8bed79ee3c4d48b1a98b5f4584c642d0 |z kostenfrei |
| 856 | 4 | 0 | |u http://journal.umpalangkaraya.ac.id/index.php/bjop/article/view/1412 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2621-4814 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2020 |e Special-1 |h 103-120 | ||